?>
Plan Name | VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN |
Plan identification number | 502 |
401k Plan Type | Welfare Benefit |
Plan Features/Benefits |
|
Company Name: | BAUSCH HEALTH US LLC |
Employer identification number (EIN): | 330949894 |
NAIC Classification: | 325410 |
Additional information about BAUSCH HEALTH US LLC
Jurisdiction of Incorporation: | Texas Secretary of State |
Incorporation Date: | 2009-06-03 |
Company Identification Number: | 0801130506 |
Legal Registered Office Address: |
400 SOMERSET CORPORATE BLVD BRIDGEWATER United States of America (USA) 08807 |
More information about BAUSCH HEALTH US LLC
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
502 | 2022-01-01 | ||||
502 | 2021-01-01 | ||||
502 | 2020-01-01 | ||||
502 | 2019-01-01 | ||||
502 | 2018-01-01 | ||||
502 | 2017-05-01 | MARY EGAN |
Measure | Date | Value |
---|---|---|
2022: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2022 401k membership | ||
Total participants, beginning-of-year | 2022-01-01 | 1,507 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 1,505 |
Number of retired or separated participants receiving benefits | 2022-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 1 |
Total of all active and inactive participants | 2022-01-01 | 1,506 |
2021: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2021 401k membership | ||
Total participants, beginning-of-year | 2021-01-01 | 6,141 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 6,139 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 1 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 5 |
Total of all active and inactive participants | 2021-01-01 | 6,145 |
2020: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2020 401k membership | ||
Total participants, beginning-of-year | 2020-01-01 | 6,419 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 6,135 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 1 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 5 |
Total of all active and inactive participants | 2020-01-01 | 6,141 |
2019: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2019 401k membership | ||
Total participants, beginning-of-year | 2019-01-01 | 5,860 |
Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 6,401 |
Number of retired or separated participants receiving benefits | 2019-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 18 |
Total of all active and inactive participants | 2019-01-01 | 6,419 |
2018: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2018 401k membership | ||
Total participants, beginning-of-year | 2018-01-01 | 5,479 |
Total number of active participants reported on line 7a of the Form 5500 | 2018-01-01 | 5,856 |
Number of retired or separated participants receiving benefits | 2018-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2018-01-01 | 4 |
Total of all active and inactive participants | 2018-01-01 | 5,860 |
2017: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2017 401k membership | ||
Total participants, beginning-of-year | 2017-05-01 | 6,036 |
Total number of active participants reported on line 7a of the Form 5500 | 2017-05-01 | 5,474 |
Number of retired or separated participants receiving benefits | 2017-05-01 | 5 |
Number of other retired or separated participants entitled to future benefits | 2017-05-01 | 0 |
Total of all active and inactive participants | 2017-05-01 | 5,479 |
2022: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2022 form 5500 responses | ||
---|---|---|
2022-01-01 | Type of plan entity | Single employer plan |
2022-01-01 | Submission has been amended | No |
2022-01-01 | This submission is the final filing | No |
2022-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2022-01-01 | Plan is a collectively bargained plan | No |
2022-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
2022-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
2021: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2021 form 5500 responses | ||
2021-01-01 | Type of plan entity | Single employer plan |
2021-01-01 | Submission has been amended | No |
2021-01-01 | This submission is the final filing | No |
2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2021-01-01 | Plan is a collectively bargained plan | No |
2021-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
2021-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
2020: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2020 form 5500 responses | ||
2020-01-01 | Type of plan entity | Single employer plan |
2020-01-01 | Submission has been amended | No |
2020-01-01 | This submission is the final filing | No |
2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2020-01-01 | Plan is a collectively bargained plan | No |
2020-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
2020-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
2019: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2019 form 5500 responses | ||
2019-01-01 | Type of plan entity | Single employer plan |
2019-01-01 | Submission has been amended | No |
2019-01-01 | This submission is the final filing | No |
2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2019-01-01 | Plan is a collectively bargained plan | No |
2019-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
2019-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
2018: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2018 form 5500 responses | ||
2018-01-01 | Type of plan entity | Single employer plan |
2018-01-01 | Submission has been amended | No |
2018-01-01 | This submission is the final filing | No |
2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2018-01-01 | Plan is a collectively bargained plan | No |
2018-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
2018-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
2017: VALEANT PHARMACEUTICALS INTERNATIONAL SEVERANCE PAY PLAN 2017 form 5500 responses | ||
2017-05-01 | Type of plan entity | Single employer plan |
2017-05-01 | First time form 5500 has been submitted | Yes |
2017-05-01 | Submission has been amended | No |
2017-05-01 | This submission is the final filing | No |
2017-05-01 | This return/report is a short plan year return/report (less than 12 months) | Yes |
2017-05-01 | Plan is a collectively bargained plan | No |
2017-05-01 | Plan funding arrangement – General assets of the sponsor | Yes |
2017-05-01 | Plan benefit arrangement – General assets of the sponsor | Yes |